Celecoxib for Treatment of Nocturia Caused by Benign Prostatic Hyperplasia: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Roehborn, 2007, Prostatic hyperplasia: Etiology, pathophysiology, epidemiology and natural history, 2727 Gerber, 2007, Evaluation of the urologic patients: History, physical examination, and urinalysis, 81 Van Kerrebroeck, 2002, The standardization of terminology in nocturia: Report from Standardization Sub-Committee of the International Continence Society, Neurourol Urodyn, 21, 179, 10.1002/nau.10053 Araki, 2004, Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia, Acta Med Okayama, 58, 45 Stewart, 1992, Nocturia: A risk factor for falls in the elderly, J Am Geriatr Soc, 40, 1217, 10.1111/j.1532-5415.1992.tb03645.x Herbert, 1993, Evidences that separate PGE2 receptors modulate water and sodium transport in rabbit cortical collecting duct, Am J Physiol, 265, 643 Maggi, 1992, Prostanoids as local modulators of reflex micturition, Pharmacol Rev, 25, 13 Wen, 1997, Nephrotoxicities of nonsteroidal anti-inflammatory drugs, J Formos Med Assoc, 96, 157 Di Silverio, 2003, Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis, Eur Urol, 43, 164, 10.1016/S0302-2838(02)00548-1 Nickel, 1999, Asymptomatic inflammation and/or infection in BPH, BJU Int, 84, 976, 10.1046/j.1464-410x.1999.00352.x De Marzo, 1999, Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis, Am Pathol, 155, 1985, 10.1016/S0002-9440(10)65517-4 Johnson, 2003, Changes in nocturia from medical treatment of benign prostatic hyperplasia: Secondary analysis of the Department of Veterans Affairs Cooperative Study trial, J Urol, 170, 145, 10.1097/01.ju.0000069827.09120.79 Le Fanu, 2001, The value of aspirin in controlling the symptoms of nocturnal polyuria, BJU Int, 88, 126, 10.1046/j.1464-410X.2001.02239-4.x Sanjai, 2006, Diclofenac for treatment of nocturia caused by nocturnal polyuria, Eur Urol, 49, 720, 10.1016/j.eururo.2005.11.026 Al-Waili, 2002, Increased urinary nitrite excretion in primary enuresis: Effects of indomethacin treatment on urinary and serum osmolality and electrolytes, urinary volumes and nitrite excretion, BJU Int, 90, 294, 10.1046/j.1464-410X.2002.02803.x Wang, 2004, Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2 and cell proliferation in glandular epithelium, Prostate, 61, 60, 10.1002/pros.20061 Warner, 2004, Cyclooxygenases: New forms, new inhibitors, and lessons from the clinic, FASEB J, 18, 790, 10.1096/fj.03-0645rev O'Neill, 1993, Expression of mRNA for cyclooxygenase 1 and 2 in human tissues, FEBS Lett, 330, 156, 10.1016/0014-5793(93)80263-T Hussain, 2003, Cyclooxygenase 2 and prostate carcinogenesis, Cancer Lett, 191, 125, 10.1016/S0304-3835(02)00524-4 Dilger, 2002, Effect of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects, J Clin Pharmacol, 42, 985, 10.1177/009127000204200905 Rossat, 1999, Renal effect of selective cyclo oxygenase-2 inhibition in normotensive salt-depleted subjects, Clin Pharmacol Ther, 66, 76, 10.1016/S0009-9236(99)70056-1 Alslameh, 2003, Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor, Aliment Pharmacol Ther, 17, 489, 10.1046/j.1365-2036.2003.01460.x